DCGI gives approval for human clinical trials of COVAXIN

Drug Controller General of India (DCGI) has given approval for human clinical trials of COVAXIN, the first potential COVID-19 Vaccine developed in India. The potential vaccine has been developed by Hyderabad-based Bharat Biotech, in association with Indian Council for Medical Research (ICMR). Human Trials for Phase I and Phase II are scheduled to start across the country from next month.

source https://www.pharmatutor.org/pharma-news/2020/dcgi-gives-approval-for-human-clinical-trials-of-covaxin